Sochetanie antagonistov kal'tsiya i ingibitorov APF u bol'nykh arterial'noy gipertenziey
- Authors: Arkhipov V.1
-
Affiliations:
- Issue: Vol 18, No 8 (2007)
- Pages: 62-64
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115363
- ID: 115363
Cite item
Abstract
Full Text
References
- Давидович И. М., Петричко Т. А. Комбинированная терапия амлодипином и лизиноприлом в лечении больных артериальной гипертонией: эффективность низкодозовой комбинации // Тер. арх. - 2006. - 78 (5): 65-68.
- Bangalore S., Kamalakkannan G., Panjrath G. et al. Fixed-dose combination improves medication compliance: a meta-analysis // J. Clin. Hypertens. -2006; 8 (suppl A): 72.
- Combination Pharmacotherapy and Public Health Research Working Group. Combination Pharmacotherapy for Cardiovascular Disease // Ann. Intern. Med. -2005; 143: 593-599.
- Dahlof B., Sever P. S., Poulter N. R. et al. ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as reguired versus atenolol adding bendoflumethiazide as reguired, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial // Lancet. - 2005; 366: 895-906.
- Dickerson J. E., Hingorani A. D., Ashby M. J. et al. Optimisation of antihypertensive treatment by crossover rotation of four major classes // Lancet. -1999; 353: 2008-2013.
- Farsang Csaba a HAMLET Vizsgalok neveben. A lisinopril es az amlodipin kombinaciojanak elonyei az antihypertensiv terapiaban. A Hypertoniaban adott Amlodipin 5 mg e′s Lisinopril 10 mg tabletta′k hate′konysa′ga′nak e′s tolera′lhato′sa′ga′nak oЁsszehasonli′to′ vizsga′lata kuЁloЁn e′s EgyuЁtt alkalmazott Tera′piake′nt (HAMLET). Multicentrikus vizsga′lat eredme′nyei // Hypertonia e′s nephrologia. – 2004. – 8 (2): 72–78.
- Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) // Journal of Hypertension. – 2007, 25: 1105–1187.
- Hansson L., Zanchetti A., Carruthers S. G. tt al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial // Lancet. – 1998; 351: 1755–1762.
- Holzgreve H. Combination versus monotherapy as initial treatment in hypertension // Herz. – 2003; 28 (8): 725–732.
- Law M. R., Wald N. J., Morris J. K., Jordan R. E. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials // BMJ. – 2003; 326: 1427 (28 June).
- Materson B. J., Reda D. J., Cushman W. C. Department of Veterans Affairs single-drug therapy of hypertension study. Revised figures and new data. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents // Am. J. Hypertens. – 1995; 8: 189–192.
- Morgan T. O., Anderson A. I., MacInnis R. J. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension // Am. J. Hypertens. – 2001; 14: 241–247.
- Naidu M. U., Usha P. R., Rao T. R., Shobha J. C. Evaluation of amlodipine, lisinopril, and a combination in the treatment of essential hypertension // Postgrad. Med. J. – 2000; 76 (896): 350–353.
- Sica D. A. Rationale for fixed-dose combinations in the treatment of hypertension: The cycle repeats // Drugs. – 2002; 62: 443–462.
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Доступно на сайте: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.htm